Laxman Ramani, MD
Obstetrics & Gynecology · Stockbridge, GANPI 1447231204
Payments from drug & device makers
What this record shows
This record is dominated by education: $8,511 of the $13,932 with a category attached, or 61.1%. Intuitive Surgical accounts for 68.2% of it on its own, with 42 other manufacturers making up the rest. Reporting peaked in 2023 at $8,577 and has fallen 71.8% since, to $2,419 in 2025. Among obstetrics & gynecology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 229 payments — averaging $60.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$10K
- AbbVie$782
- Mayne Pharma Commercial LLC$502
- Astellas Pharma US Inc$451
- Daiichi Sankyo Inc.$310
- Bayer$207
- plus $2K from 37 others
What the payments were for
- Travel & lodging$7876%
- Food & beverage$4,63433%
- Education$8,51161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 22 | $9,505 |
| AbbVie | 39 | $782 |
| Mayne Pharma Commercial LLC | 25 | $502 |
| Astellas Pharma US Inc | 16 | $451 |
| Daiichi Sankyo Inc. | 18 | $310 |
| Bayer | 11 | $207 |
| Boston Scientific | 3 | $173 |
| Coopersurgical, Inc. | 5 | $169 |
| Gynesonics, Inc. | 1 | $146 |
| Biogen | 6 | $138 |
| Sumitomo Pharma America, Inc. | 6 | $124 |
| Exeltis, USA Inc. | 7 | $118 |
| Shield Therapeutics Inc | 5 | $112 |
| Millicent US Inc | 4 | $109 |
| Mylan Pharmaceuticals Inc. | 7 | $98 |
| Caldera Medical, Inc | 2 | $95 |
| Optumhealth Care Solutions, LLC | 4 | $84 |
| Organon | 5 | $74 |
| Evofem Biosciences, Inc. | 4 | $68 |
| Amgen | 3 | $66 |
| Therapeuticsmd, Inc. | 4 | $65 |
| Hologic Sales And Service, LLC | 3 | $56 |
| Pfizer | 3 | $52 |
| Merck | 2 | $35 |
| Agile Therapeutics, Inc. | 2 | $33 |
| Monaghan Medical Corporation | 1 | $31 |
| Radius Health, Inc. | 2 | $30 |
| Scynexis, Inc. | 2 | $29 |
| Lupin Inc. | 2 | $25 |
| Avion Pharmaceuticals | 2 | $25 |
| Northgate Technologies, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| BD | 1 | $20 |
| Femselect Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
| Baxter Healthcare | 1 | $15 |
| Medtronic | 1 | $15 |
| Myovant Sciences Inc. | 1 | $14 |
| Novo Nordisk | 1 | $14 |
| Avanos Medical | 1 | $13 |
| Channel Medsystems, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,932 in reported general payments places this provider in the 95th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 107 | $5,419 |
| MyrbetriqMirabegron | 11 | $4,650 |
| Metronidazole | 17 | $657 |
| ProgesteroneProgesterone, Micronized | 12 | $603 |
| ValacyclovirValacyclovir Hcl | 18 | $520 |
| Ibandronate Sodium | 19 | $282 |
| Tinidazole | 14 | $271 |
| Clobetasol Propionate | 17 | $151 |
| Alendronate Sodium | 27 | $134 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $133 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 13 | $114 |
| Fluconazole | 22 | $59 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $451 | $4,65011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Other obstetrics & gynecology in Stockbridge
- Elisheba ButtsStockbridge$13K
- Edmund KimLawrenceville$628K
- Jacquelin WaltersDuluth$147K
- Nicole SparksJohns Creek$121K
- Lethenia BakerThomaston$111K
- Renee AllenAtlanta$74K
- Matthew RalstenFayetteville$64K
- Murray FreedmanAugusta$48K
- Tosha Rogers-JonesAtlanta$46K
- Teresa ByrdMarietta$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.